Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3

US Patent 11357778 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and pharmaceutical compositions for the treatment of FGFR3-related chond2025
Methods and pharmaceutical compositions for the treatment of FGFR3-related chond2024
Treatment and prediction of therapeutic responses in patients suffering from Fri2024
Methods for performing antisense oligonucleotide-mediated exon skipping in the r2023
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2018
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2018
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2018
Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the tre2018
Methods for the treatment and diagnosis of bone mineral density related diseases2017
Spinal muscular atrophy diagnostic methods2015
Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy2013
Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of gen2012